| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/17/2009 | US20090311702 Tests to predict responsiveness of cancer patients to chemotherapy treatment options |
| 12/17/2009 | US20090311701 Organ-specific gene, method for identifying the same and use thereof |
| 12/17/2009 | US20090311700 Methods for Breast Cancer Prognosis |
| 12/17/2009 | US20090311699 Method of surface plasmon resonance (spr) to detect genomic aberrations in patients with chronic lymphocytic leukemia |
| 12/17/2009 | US20090311698 Diagnostic assay |
| 12/17/2009 | US20090311697 Methods for screening for genetic predisposition to type i diabetes |
| 12/17/2009 | US20090311696 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 12/17/2009 | US20090311695 Method |
| 12/17/2009 | US20090311694 Splice variants of human IL-23 receptor (IL-23R) mRNA and use of a delta 9 isoform in predicting inflammatory bowel diseases |
| 12/17/2009 | US20090311693 Method for the in vitro screening of anti-cancer compounds that inhibits sk3 activity, and said anti-cancer compounds |
| 12/17/2009 | US20090311692 Isolation of nucleic acid from mouth epithelial cells |
| 12/17/2009 | US20090311691 sequencing; allow the generation of additional information about the location of short sequence reads in a genome |
| 12/17/2009 | US20090311690 Vector for screening antibody |
| 12/17/2009 | US20090311689 Genomic marker for tenderness meat |
| 12/17/2009 | US20090311688 Novel Labeled oligonucleotide |
| 12/17/2009 | US20090311687 Microorganisms detection and enumeration method |
| 12/17/2009 | US20090311686 Method relating to sweetness enhancement |
| 12/17/2009 | US20090311685 NMU-GHSR1b/NTSR1 oncogenic signaling pathway as a therapeutic target for lung cancer |
| 12/17/2009 | US20090311684 Enhanced fc receptor-mediated tumor necrosis factor superfamily and chemokine mrna expression in peripheral blood leukocytes in patients with rheumatoid arthritis |
| 12/17/2009 | US20090311683 Compositions for the use in identification of fungi |
| 12/17/2009 | US20090311682 Combination of avian cell markers |
| 12/17/2009 | US20090311681 Pharmacodiagnostic test targeting oncology and neurodegeneration |
| 12/17/2009 | US20090311680 Method for Identifying Useful Proteins of Brewery Yeast |
| 12/17/2009 | US20090311679 TaqMan MGB probe useful for detecting the mitochondrial gene C1494T mutation associated with maternally inherited deafness and the use thereof |
| 12/17/2009 | US20090311678 Method of discriminating at least two cell populations, and application |
| 12/17/2009 | US20090311677 Identification of contaminating bacteria in industrial ethanol fermentations |
| 12/17/2009 | US20090311676 Method for preparing primer used for determining the mutation in PDS gene related to large vestibular aqueduct syndrome in vitro and the use of the primer |
| 12/17/2009 | US20090311675 Apparatus for Monitoring Thrombus Formation and Method of Mointoring Thrombus Formation |
| 12/17/2009 | US20090311674 Phosphate Biosensors and Methods of Using the Same |
| 12/17/2009 | US20090311673 Devices for PCR and for observing nucleic acid hybridization with fluorescence dye during and/or immediately after PCR and using this information for product identification, sequence alteration detection, and quantification; fluorescence resonance energy transfer (fret) |
| 12/17/2009 | US20090311672 Detection of amplicon contamination during pcr exhibiting two different annealing temperatures |
| 12/17/2009 | US20090311671 Diagnosis of risk of breast cancer |
| 12/17/2009 | US20090311670 Apparatus and method for measuring concentration of molecules through a barrier |
| 12/17/2009 | US20090311669 Signal for packaging of influenza virus vectors |
| 12/17/2009 | US20090311668 In situ detection of early stages and late stages HPV einfection |
| 12/17/2009 | US20090311667 Rapid diagnosis method specific to avian influenza virus |
| 12/17/2009 | US20090311666 Microfluidic device for crystallization and crystallographic analysis of molecules |
| 12/17/2009 | US20090311665 Methods, compositions, and kits for collecting and detecting oligonucleotides |
| 12/17/2009 | US20090311664 Method for Detection of Cancer Cells Using Virus |
| 12/17/2009 | US20090311313 Methods for treating tweak-related conditions |
| 12/17/2009 | US20090311287 Novel flavivirus antigens |
| 12/17/2009 | US20090311283 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
| 12/17/2009 | US20090311278 Novel teleost derived antimicrobial polypeptides |
| 12/17/2009 | US20090311277 Nucleic acid compositions for stimulating immune responses |
| 12/17/2009 | US20090311269 Methods for collecting and detecting oligonucleotides |
| 12/17/2009 | US20090311265 Human binding molecules capable or neutralizing influenze virus h5n1 and uses thereof |
| 12/17/2009 | US20090311263 Human vascular ibp-like growth factor |
| 12/17/2009 | US20090311261 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 12/17/2009 | US20090311260 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 12/17/2009 | US20090311256 12 Human Secreted Proteins |
| 12/17/2009 | US20090311250 Methods and compositions for the diagnosis and treatment of cancer |
| 12/17/2009 | US20090311248 Hepatitis C Virus Neutralizing Antibodies |
| 12/17/2009 | US20090311244 Screening Method |
| 12/17/2009 | US20090311243 Methods for Identifying FZD8 Modulators and the Use of such Modulators for Treating Osteoarthritis |
| 12/17/2009 | US20090311242 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a) |
| 12/17/2009 | US20090311233 Materials and methods directed to asparagine synthetase and asparaginase therapies |
| 12/17/2009 | US20090311224 Therapeutic agent comprising lipocalin 2 against cancer metastasis, and methods of early diagnosis and inhibition of cancer metastasis using lipocalin 2 |
| 12/17/2009 | US20090311216 Recombinant interferon-beta with enhanced biological activity |
| 12/17/2009 | US20090311214 Compositions and methods for the innate immune response pathway |
| 12/17/2009 | US20090311185 Peptide having antianxiety activity and screening method therefor |
| 12/17/2009 | US20090311184 High penetration prodrug compositions of peptides and peptide-related compounds |
| 12/17/2009 | US20090311180 Protein Isoforms and Uses Thereof |
| 12/17/2009 | US20090311175 Methods for treating thyroid cancer |
| 12/17/2009 | US20090310839 Systems and methods to perform inhibition diagnostic testing |
| 12/17/2009 | US20090310743 Test-Sensor Production Monitoring Using XRF Spectrometry |
| 12/17/2009 | US20090308741 Sensor arrangement comprising an electrode for detecting diffused loaded particles |
| 12/17/2009 | US20090308736 Apparatus and method for specific release of captured extension products |
| 12/17/2009 | US20090308324 Diabetes tests |
| 12/17/2009 | CA2765422A1 Single strand dimensional construction of dna in 3d space |
| 12/17/2009 | CA2763548A1 Brown adipocyte progenitors in human skeletal muscle |
| 12/17/2009 | CA2737141A1 Human mena isoforms serve as markers of epithelial to mesenchymal transition and sensitivity to egfr inhibition in human cancer cells |
| 12/17/2009 | CA2728232A1 Cell lysis reagent for isolation of rna |
| 12/17/2009 | CA2727795A1 Genetic component of complications in type 2 diabetes |
| 12/17/2009 | CA2727709A1 Nucleotides and nucleosides and methods for their use in dna sequencing |
| 12/17/2009 | CA2727681A1 Programming and reprogramming of cells |
| 12/17/2009 | CA2727633A1 Use of mir-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy |
| 12/17/2009 | CA2727430A1 Constructs for expressing herbicide tolerance genes, related plants, and related trait combinations |
| 12/17/2009 | CA2727247A1 Thymidylate synthase haplotype is associated with tumor recurrence in stage ii and stage iii colon cancer patients |
| 12/17/2009 | CA2727212A1 Isothermal nucleic acid amplification |
| 12/17/2009 | CA2726850A1 Method of synthesizing polynucleotide variants |
| 12/17/2009 | CA2726118A1 Method for screening for compounds that inhibit neurodegeneration |
| 12/17/2009 | CA2726080A1 A method for autism prediction |
| 12/17/2009 | CA2726078A1 A combination of risk alleles associated with autism |
| 12/17/2009 | CA2725239A1 Chemically modified nucleoside 5'-triphosphates for thermally initiated amplification of nucleic acid |
| 12/17/2009 | CA2718337A1 Direct selection of structurally defined aptamers |
| 12/17/2009 | CA2717045A1 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof |
| 12/16/2009 | EP2133880A2 Recording medium, playback device, recording method, playback method, and computer program |
| 12/16/2009 | EP2133692A1 Diagnosis method for fatty liver disease, diagnosis apparatus, diagnosis program, diagnostic agent, and method for screening for therapeutic agent for fatty liver disease |
| 12/16/2009 | EP2133434A1 Method for the detection of target nucleic acid |
| 12/16/2009 | EP2133433A1 A method for predicting responsiveness to a treatment with an anti-HER2 antibody |
| 12/16/2009 | EP2133432A1 Use of snail1 activity inhibiting compounds in the preparation of pharmaceutical compositions intended for the treatment of chondrodystrophies, method for identifying inhibiting compounds, pharmaceutical compositions, chondrodystrophy diagnosis method and applications thereof |
| 12/16/2009 | EP2133431A1 Micrornas in serum/blood plasma and their uses |
| 12/16/2009 | EP2133430A2 Design and therapeutic use of adpase enhanced apyrases |
| 12/16/2009 | EP2133423A1 Germ cell marker using fish vasa gene |
| 12/16/2009 | EP2133422A1 Biological substance analysis chip, biological substance analysis kit and method of biological substance analysis using them |
| 12/16/2009 | EP2132984A2 Interferon-like protein ZCYTO21 |
| 12/16/2009 | EP2132573A2 Predicting response to a her dimerisation inhbitor based on low her3 expression |
| 12/16/2009 | EP2132569A1 A cell-mediated immune response assay and kits therefor |
| 12/16/2009 | EP2132568A1 Method of determining risk of scoliosis |
| 12/16/2009 | EP2132549A1 Alkyl amines improve detection of components of formaldehyde-fixed biological samples |